Project Details
| Status | Active |
|---|---|
| Effective start/end date | 1/06/26 → 31/05/30 |
Collaborative partners
- Imperial College London (lead)
Funding
- Medical Research Council: £1,033,223.89
Harnessing the glucose lowering actions of alpha-melanocyte stimulatory hormone as a potential new adjunctive therapy for people with type 2 diabetes mellitus
- Miras, Alexander (PI)
- le Roux, Carel (CoI)
- Tanday, Neil (CoI)
- Price, Ruth (CoI)
- Zhang, Shu-Dong (CoI)
Project: Research